Clinical Trials
- Digestive System
Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
- Ages12 years - 75 years
- GenderBoth
- Date04/09/2021
- Addictive Behavior
Combining Varenicline and Guanfacine for Smoking Cessation
- Ages18 years and older
- GenderBoth
- Date02/11/2020
- Digestive System
Efficacy & Safety of Risankizumab in Subjects with Moderately to Severely Active Ulcerative Colitis
- Ages16 years - 80 years
- GenderBoth
- Date07/22/2021